GUILD 2021

Add to Calendar GUILD 2021 2/13/2021 3:30:00 PM 2/17/2021 1:30:00 PM Pacific/Honolulu For More Details: https://uc.cloud-cme.com/course/courseoverview?EID=27379 Description: With the tremendous recent advances in inflammatory bowel disease, liver disease, and general gastroenterology, keeping abreast of new developments has become a challenge. This outstanding meeting, run by a world-class faculty*, will review key aspects relevant to: IBD; ulcerative colitis; Crohn’s disease; viral hepatitis; NAFLD; irritable bowel syndrome; endoscopic and medical management of obesity; and ... Hawaii Time - Wailea Marriott, 3700 Wailea Alanui Drive false MM/DD/YYYY


Date & Location
Saturday, February 13, 2021, 3:30 PM - Wednesday, February 17, 2021, 1:30 PM, Hawaii Time - Wailea Marriott, 3700 Wailea Alanui Drive

Credits
AMA PRA Category 1 Credits™ (25.50 hours), ABIM MOC Part 2 (25.50 hours), ABP MOC Part 2 (25.50 hours), AMA PRA Category 1 Credits™ Designated (25.50 hours)

Target Audience
Specialties - Gastroenterology

Overview
With the tremendous recent advances in inflammatory bowel disease, liver disease, and general gastroenterology, keeping abreast of new developments has become a challenge. This outstanding meeting, run by a world-class faculty*, will review key aspects relevant to: IBD; ulcerative colitis; Crohn’s disease; viral hepatitis; NAFLD; irritable bowel syndrome; endoscopic and medical management of obesity; and much more! The format has been specifically designed to allow optimal time for discussion and interaction.

Registration

To register for this fabulous conference, please go to: https://guildconference.com/2021/registration-information-2021/

The registration fees can also be found at the above website.


Objectives
Upon completion of this activity, learners should be able to:

  1. Describe the latest treatment options for ulcerative colitis and apply them in practice
  2. Describe the latest treatment options for Crohn’s disease and apply them in practice
  3. Discuss management of complications of IBD including abdominal abscess, infection and malignancy
  4. Explain how to optimize management of IBD in the older patient
  5. Recognize and manage new onset IBD
  6. Recognize rheumatologic and dermatologic complications of IBD
  7. Recognize and manage checkpoint inhibitor colitis
  8. Describe the latest treatment options for Screening & Servaillance of colon cancer
  9. Describe the latest treatment options for Nonalcoholic Fatty Liver Disease and the Autoimmune hepatitis
  10. Evaluate the patient with primary sclerosing cholangitis

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Excellence in Gastroenterology Education, LLC. 

The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this live activity for a maximum of 25.5 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Additional Information
The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.